YDESWNasdaq United StatesHealth CareMedical Specialities
Market cap
$25.499 M
$0.36 +0.00%
Close of 23 Sept 2026
Revenue
$596.8K
#3521 by revenue
Earnings
-$8.31M
Loss-making
Shares outstanding
70,789,261
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
YD Bio lists more than one class of stock. Company figures above cover all classes combined.
Where these numbers come from
Share counts and financials for YD Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 24 Sept 2026. Read the methodology.